Tuberculosis screening and compliance with return for skin test reading among active drug users

American Journal of Public Health

Volumn 88, Issue 5, 1998, Pages 792-796

  Malotte, C Kevin ^a,b   Rhodes, Fen ^a   Mais, Kathleen E ^c  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b Center for Behavioral Research and Services   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; TUBERCULIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONEY; MOTIVATION; PATIENT COMPLIANCE; PATIENT EDUCATION; PREVALENCE; SCREENING; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0031842469     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.88.5.792     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention. Screening for tuberculosis and tuberculosis infection in high-risk populations: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1995;44(RR-11):18-34.
2. Graham NMH, Nelson KE, Solomon L, et al. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. JAMA. 1992;267:369-373.
3. Reichman LB, Felton CP, Edsall JR. Drug dependence, a possible new risk factor for tuberculosis disease. Arch Intern Med. 1979;139:337-339.
4. Centers for Disease Control. Crack cocaine use among persons with tuberculosis - Contra Costa County, California, 1987-1990. MMWR Morb Mortal Wkly Rep. 1991;40:485-489.
5. Leonhardt KK, Gentile F, Gilbert BP, Aiken M. A cluster of tuberculosis among crack house contacts in San Mateo County, California. Am J Public Health. 1994;84:1834-1836.
6. Centers for Disease Control. Prevention and control of tuberculosis in US communities with at-risk minority populations: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1992;40(RR-5).
7. Nazar-Stewart V, Nolan CM. Results of a directly observed intermittent isoniazid preventive therapy program in a shelter for homeless men. Am Rev Respir Dis. 1992;146:57-60.
8. Weis SE, Slocum PC, Biais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med. 1994;330:1179-1183.
9. Fishbein M, Ajzen I. Belief, Attitude, Intention and Behavior: An Introduction to Theory and Research. Reading, Mass: Addison-Wesley; 1975.
10. Fishbein M, Middlestadt SE, Hitchcock PJ. Using information to change sexually transmitted disease-related behaviors: an analysis based on the theory of reasoned action. In: Wasserheit JN, Aral SO, Holmes KK, Hitchcock PJ, eds. Research Issues in Human Behavior and Sexually Transmitted Diseases in the AIDS Era. Washington, DC: American Society for Microbiology; 1991:243-257.
11. Sumartojo E. When tuberculosis treatment fails: a social behavioral account of patient adherence. Am Rev Respir Dis. 1993;147:1311-1320
12. Cuneo WD, Snider DE Jr. Enhancing patient compliance with tuberculosis therapy. Clin Chest Med. 1989;10:375-380.
13. Sbarbaro JA. Compliance: inducements and enforcements. Chest. 1979;76(suppl):750-756.
14. Pozsik C, Kinney J, Breeden D, Niven B. Davis T. Approaches to improving adherence to antituberculosis therapy - South Carolina and New York, 1986-1991. MMWR Morb Mortal Wkly Rep. 1993;42:74-75, 81.
15. Snider DE Jr, Anders HM, Pozsik CJ. Incentives to take up health services. Lancet. 1986;2:812.
16. Morisky DE, Malotte CK. Choi P, et al. A patient education program to improve adherence rates with antituberculosis drug regimens. Health Educ Q. 1990;17:253-267.
17. Pilote L, Tulsky JP, Zolopa AR, Hahn JA, Schecter GF, Moss AR. Tuberculosis prophylaxis in the homeless. Arch Intern Med. 1996;156:161-165.
18. Centers for Disease Control. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR Morb Mortal Wkly Rep. 1991;40(RR-5):27-33.
19. SPSS Base System Syntax Reference Guide, Release 5.0. Chicago, Ill: SPSS Inc; 1992.
20. Chaisson RE, Keruly JC, McAvinue S, Gallant JE, Moore RD. Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection. J Acquir Immune Defic Syndr. 1996;11:455-459.
21. Deren S, Stephens R, Davis WR, Feucht TE, Tortu S. The impact of providing incentives for attendance at AIDS prevention sessions. Public Health Rep. 1994;109:548-554.
22. Higgins ST, Budney AJ, Bickel WK, Foerg FE, Donham R, Badger GJ. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry. 1994;51:568-576.
23. MacGregor RR, Dunbar D, Graziani AL. Tuberculin reactions among attendees at a methadone clinic: relation to infection with the human immunodeficiency virus. Clin Infect Dis. 1994;19:1100-1104.
24. McAdam JM, Brickner PW, Scharer LL, et al. Tuberculosis in the homeless: a national perspective. In: Brickner PW, Scharer LL, Conanen BA, Savarese M, Scanlan BC, eds. Under the Safety Net. New York, NY: WW Norton & Co; 1990:234-249.
25. Zolopa AR, Hahn JA, Gorter R, et al. HIV and tuberculosis infection in San Francisco's homeless adults: prevalence and risk factors in a representative sample. JAMA. 1994;272:455-461.